Skip to main content
 ÐÄʳÉñ > ÃÀʳ >

Òûʳ¸ÉÔ¤¶ÔÈÑÉïÌÇÄò²¡»¼ÕßÓªÑø´úл¼°ÈÑÉï½á¾ÖµÄÓ°Ïì

2021-04-24 00:16

2010 Äê 5 ÔÂµÚ 7 ¾íµÚ 15 ÆÚ¡¤ÂÛ Öø¡¤ÓªÑø¸ÉÔ¤¶ÔÈÑÉïÆÚÌÇÄò²¡»¼ÕßÓªÑø´úлµÄÓ°ÏìÒüȺ·¼ 1£¬Àî Çå 2£¬³Â½¡»ª 2£¬ÖÓ»ÛÇä 2£¬³Â´º¶ð 2£¬ÖÜÀö¾ê 2 £¨1.¹ã¶«Ê¡¶«Ý¸ÊÐÈËÃñÒ½ÔºÓªÑø¿Æ£¬¹ã¶«¶«Ý¸ 523018£»2.¹ã¶«Ê¡¶«Ý¸ÊÐÈËÃñÒ½Ôº¸¾²ú¿Æ£¬¹ã¶«¶«Ý¸ 523018£©[ÕªÒª] Ä¿µÄ£ºÌ½ÌÖÒûʳ¸ÉÔ¤¶ÔÈÑÉïÌÇÄò²¡£¨gestational diabetes mellitus£¬GDM£©»¼ÕßµÄÓ°Ïì¡£ ·½·¨£º¶Ô 90 ÀýÃ÷È·Õï¶ÏΪGDM µÄÔи¾Öƶ©¸öÌ廯µÄÒûʳ·½°¸£¬¸ù¾ÝÔÐÆÚ·Ö±ð½áºÏÔÐÇ°±ê×¼ÀíÏëÌåÖؼÆËãÿÈÕËùÐèÄÜÁ¿ £¬¼à²âÒûʳÖÎÁÆÇ°ºóµÄѪÌÇ¡¢ÌÇ»¯Ñªºìµ°°×¡¢ÑªÇåÇåµ°°×¡¢Èýõ£¸ÊÓÍ¡¢µ¨¹Ì´¼Ë®Æ½¼°Ó¤¶ù³öÉúÌåÖØ¡£ ½á¹û£ºÒûʳÖÎÁƺóѪÌÇ¡¢ÌÇ»¯Ñªºìµ°°× ¡¢Èý õ£ ¸Ê ÓÍ Ë® ƽ ½Ï ÖÎ ÁÆ Ç° Ã÷ ÏÔ Ï ½µ £¬²î Òì ÓРͳ ¼Æ ѧ Òâ Òå £¨P0.05). The mean weight of infants was (3 058¡À769) g, There was no giant fetus. Conclusion: Diet therapy has obvious therapeutic effect on patients with GDM, it can improve the glucose and fat metabolism, thus win a better pregnancy out come. [Key words] GDM; Nutrition metabolism; Nutrition intervention; Pregnancy outcome; Blood glucoseËæ×ÅÈËÃÇÉú»îˮƽµÄÌá¸ß£¬ÈÑÉ︾ŮÉãÈëÓªÑø¹ýʣʹÈÑ Éï ÌÇ Äò ²¡ £¨gestational diabetes mellitus£¬GDM£© µÄ ·¢ ²¡ ÂÊ ³Ê Öð ÄêÉÏÉýµÄÇ÷ÊÆ£¬GDM ¸øÔи¾ºÍÌ¥¶ùµÄ½¡¿µ´øÀ´ÁËÍþв £¬ÒýÆð ÁËҽѧ½çµÄÖØÊÓ£¬ÓªÑø¸ÉÔ¤ÊÇÖÎÁƵÄÖØÒª·½·¨[1-3]¡£

±¾Ñо¿¶Ô GDM »¼Õßʵʩ¸öÌ廯ӪÑøµÄÖÎÁÆ·½°¸£¬¼ÓÇ¿¶Ô GDM Ôи¾µÄ Òûʳ¹ÜÀí¼°ÑªÌǼà²â£¬ ̽ÌÖÒûʳ¸ÉÔ¤¶Ô GDM »¼ÕßÓªÑø´úл ¼°ÈÑÉï½á¾ÖµÄÓ°Ïì¡£ 1 ×ÊÁÏÓë·½·¨ 1.1 Ò»°ã×ÊÁÏ2009 Äê 3 Ô¡«2010 Äê 1 ÔÂÔÚÎÒÔº²ú¿ÆסԺµÄ 90 Àý³õ´Î È·ÕïΪ GDM µÄ»¼Õߣ¬ÔÐÆÚ 24¡«28 ÖÜ£¬Æ½¾ùÄêÁ䣨28.3¡À3.3£©Ë꣬ ÅųýÔÐÇ°ÓÐÌÇÄò²¡Ê·¡¢»¼ÓÐÐÄ¡¢·Î¡¢¸Î¡¢ÉöµÈÖØÒªÔàÆ÷¹¦ÄÜÕÏ °­Õß¼°²ÉÓýµÌÇÒ©ÎÈçÒȵºËØ£©ÖÎÁÆÕß¡£ 1.2 ·½·¨»¼ Õß Êµ ÐÐ ¸ö Ìå »¯ Òû ʳ ¸É Ô¤ £¬ ¸ù ¾Ý ÔÐ Ç° Ìå ÖØ Ö¸ Êý £¨BMI£© [BMI=ÌåÖØ£¨kg£©/Éí¸ß£¨m2£©]¼°ÔÐÆÚÔöÖØ£¨IBW£©£¬GDM »¼ÕßÔÚ»ù ±¾ ÄÜ Á¿ £¨En£©¹© ¸ø £¨±í 1£©»ù ´¡ ÉÏ £¬¶î Íâ ÔÙ ¼Ó 200 kcal/d[4]£¬ÒÔ Âú ×ãÌ¥¶ùÐèÒª£»ÉÙÁ¿¶à²Í£¬¶à²¹³äάÉúËؼ°Î¢Á¿ÔªËØ£¬Ôö¼ÓÉÅʳ ÏËάµÄÉãÈ룻ºÏÀíµ÷ÕûÉÅʳÈÈÁ¿±ÈÀý£¨Ì¼Ë®»¯ºÏÎï¡¢Ö¬·¾¡¢µ°°×ÖÊÈÈÁ¿±È·Ö±ðÊÇ 50£¥¡«60£¥¡¢25£¥¡«30£¥¡¢15£¥¡«20£¥£©¡£ ʳ Îï Ñ¡Ôñ£ºÖ÷ʳ¶àÑ¡ÔñѪÌÇÖ¸ Êý £¨GI£©½Ï µÍ µÄ ´Ö Á¸ £¨Ñà Âó ¡¢Üñ Âó ¡¢Êí ÀàºÍÔÓ¶¹ÀàµÈº¬ÉÅʳÏËά¶àµÄʳÎ£¬ ÑϸñÏÞÖƺ¬µí·Û¶àµÄ ʳƷ£¬Èç·ÛË¿¡¢µí·Û¡¢Åº·ÛµÈ£»µ°°×ÖÊÖ÷ҪѡÔñµ°¡¢ÄÌ¡¢ÐóÈâ¡¢º£ ÏÊ ¡¢¶¹ ÖÆ Æ· £¬ÓÅ ÖÊ µ° °× Ó¦ Õ¼ ÿ ÈÕ ×Ü µ° °× µÄ 50£¥ÒÔ ÉÏ £»Êß ²Ë ³ä ×㣬ÿÈÕ¹©Ó¦²»ÉÙÓÚ 500 g£¬ÒÔ ÂÌ É« ºÍ »Æ É« Êß ²Ë Ϊ Ö÷ £»Ë® ¹û ÔÚ ÑªÌÇ¿ØÖÆ´ï±êʱ¹©¸ø£¬×îºÃÑ¡ÓûðÁú¹û¡¢èÖ×Ó¡¢³È×Ó¡¢Àî×Ó¡¢Ó£ ÌÒ¡¢ÏÊÌÒ¡¢â¨ºïÌÒ¡¢²ÝÝ®¡¢Æ»¹ûµÈ£¬Ó¦·ÅÔÚÁ½²ÍÖ®¼ä³Ô£¬Ò»´Î 100¡«150 g£¬²»Òª¹ýÁ¿Ê³Ó㬻òÒÔÎ÷ºìÊÁ¡¢»Æ¹Ï´úÌ棻Åëµ÷ÓÍÑ¡ ÓÃÖ²ÎïÓÍ£¬Êʵ±ÉÙÁ¿Ñ¡Ê³ºËÌÒ¡¢ÐÓÈʵÈÓ²¹ûÀàʳÎï¼Ó²Í£¬Ôö¼Ó µ¥²»±¥ºÍÖ¬·¾¡¢¶à²»±¥ºÍÖ¬·¾µÄ±ÈÀý£»½ûÓô¿Ì¼Ë®»¯ºÏÎïʳ Æ·£¬ÈçÌǹû¡¢ÃÛ½¤¡¢ÌðµãÐÄ¡¢Ë®¹û¹ÞÍ·¡¢Ì¼ËáÒûÁϵȣ»ºÏÀíµÄ²Í ´Î°²Åż°ÈÈÁ¿·ÖÅ䣺Ôç²Í¡¢¼Ó²Í¡¢Îç²Í¡¢¼Ó²Í¡¢Íí²Í¡¢¼Ó²Í°´ 15£¥¡«20£¥¡¢5£¥¡¢30£¥¡¢10£¥¡¢25£¥¡«30£¥¡¢5£¥·Ö Åä £¬ÓÐ Óª Ñø ³ø ʦ ¶¨ Á¿ÖÆ×÷¡£

ÌÇÄò²¡»¼ÕßÈÑÉï_ÌÇÄò²¡»¼ÕßÒûʳ_ÈÑÉïÌÇÄò²¡ÒûʳʳÆ×

GDM ʳÆ×¾ÙÀý£¬Ôç²Í£ºÅ£ÄÌ 1 ±­£¨180 ml£©£¬ÑàÂóÖà 1 Íë £¨Ñà Âó 50 g£©£¬¼¦ µ° 1 ¸ö £¨È¥ µ° »Æ £©£¬°è ÇÛ ²Ë ¶¹ ¸¯ Ƥ 1 С µú £»¼Ó ²Í £º Éú ²Ë 1 С µú £¨200 g£©£» Îç ²Í £º Ã× ·¹ £¨ ´ó Ã× 100 g£©£¬ Çå Õô Óã £¨125 g£©£¬²¤²Ë¼¦µ°ÌÀ£¨²¤²Ë 250 g£¬¼¦µ° 1 ¸ö£©£»¼Ó²Í£ºÆ»¹û 1 ¸ö £¨150 g£©£»Íí²Í£ºÃ×·¹£¨´óÃ× 75 g£©£¬Ç۲˳´ÈâË¿£¨ÇÛ²Ë 250 g£¬ÊÝCHINA MEDICAL HERALD ÖйúÒ½Ò©µ¼±¨ 13¡¤ÂÛ Öø¡¤2010 Äê 5 ÔÂµÚ 7 ¾íµÚ 15 ÆÚÈâ 50 g£©£»¼Ó²Í£ºÅ£ÄÌ 1 ±­£¨180 ml£©£¬È«ÈÕÅëµ÷ÓÍ 15 ml£¬ÑÎ 5 g¡£ Òûʳ¿ØÖƺ󼴿ªÊ¼¼à²âÓªÑø´úлָ±ê£¬ ѪÌÇ¿ØÖÆƽÎȺó 3 d ³öÔº£¬³öÔººó 30 d Ëæ·ÃѪÌÇ¡¢ÌÇ»¯Ñªºìµ°°×¡¢ÑªÇåÇåµ°°×¡¢×Ü µ¨¹Ì´¼¡¢Èýõ£¸ÊÓÍ£¬Ö±ÖÁ·ÖÃä¡£±í 1 GDM »¼Õß»ù±¾ÄÜÁ¿¹©¸øģʽTab.1 Basic energy supply model of patients with GDMÔÐÇ° BMI£¨kg/m2£© £¼20IBW£¨kg£© £¼12.5En[kcal/£¨kg¡¤d£©] 3012.5¡«18.025£¾18.015¡«2020¡«25£¼11.53011.5¡«16.025£¾16.015¡«2026¡«29£¼7.0307.0¡«11.525£¾11.515¡«20£¾30£¼6.025¡Ý6.015¡«201.3 ÁÙ´²ÆÀ¼ÛÖ¸±ê Ö÷ÒªÖ¸±êÓУº¸ÉԤǰºóµÄ¿Õ¸¹ÑªÌÇ¡¢²ÍºóѪÌÇ¡¢ÌÇ»¯Ñªºìµ°°×¡¢ÑªÇåÇåµ°°×¡¢×ܵ¨¹Ì´¼¡¢Èýõ£¸ÊÓÍ¡¢Ó¤¶ù³öÉúÌåÖØ¡¢ÐÂÉú ¶ùѪÌÇ¡¢Î§Éú¶ùËÀÍöµÈΧÉú¶ù²¢·¢Ö¢µÄ·¢²¡ÂÊ£¬·ÖÎöÓªÑø¸É Ô¤¶ÔÉÏÊöÖ¸±êµÄÓ°Ïì¡£

1.4 ͳ¼Æѧ·½·¨Êý¾Ý ÒÔ ¾ù Êý¡À±ê ×¼ ²î £¨x¡Às£©±í ʾ £¬²É Óà SPSS 13.0 Èí ¼þ ´¦ Àí£¬¶ÔÊý¾Ý½øÐÐ t ¼ìÑ飬P£¼0.05 Ϊ²îÒìÓÐͳ¼ÆѧÒâÒå¡£ 2 ½á¹û 2.1 ¸ÉԤǰºóÖ¸±ê±ä»¯90 Àý GDM »¼ Õß ¾­ ¸ö Ìå »¯ Óª Ñø ÖÎ ÁÆ ºó £¬¿Õ ¸¹ Ѫ ÌÇ ¡¢²Í ºó Ѫ ÌÇ ¡¢Èý õ£ ¸Ê ÓÍ ¾ù ½Ï ÖÎ ÁÆ Ç° Ã÷ ÏÔ Ï ½µ £¬²î Òì ÓРͳ ¼Æ ѧ Òâ Òå £¨P£¼ 0.05£©£»Ñª Çå Çå µ° °× ½Ï ÖÎ ÁÆ Ç° Éý ¸ß ¡¢×Ü µ¨ ¹Ì ´¼ ½Ï ÖÎ ÁÆ Ç° Ï ½µ £¬ µ«²îÒìÎÞͳ¼ÆѧÒâÒ壨P>0.05£©¡£ ¼û±í 2¡¢3¡£±í 2 GDM »¼ÕßÒûʳ¸ÉԤǰºóѪÌǵı仯£¨x¡Às£©Tab.2 The change of blood glucose before and after theintervention of patients with GDM (x¡Às)¿Õ¸¹ÑªÌÇ Ôç²ÍºóѪÌÇ Îç²ÍºóѪÌÇ Íí²ÍºóѪÌÇ ÌÇ»¯Ñªºìµ°°××é±ð£¨mmol/L£© £¨mmol/L£© £¨mmol/L£© £¨mmol/L£©£¨%£©¸ÉԤǰ 6.32¡À0.70 9.25¡À1.30 8.13¡À1.07 7.16¡À0.96 6.56¡À0.28¸ÉÔ¤ºó 5.01¡À0.51* 6.20¡À0.91* 5.76¡À1.75* 5.10¡À1.16* 5.06¡À0.24* Óë ¸É Ô¤ Ç° ±È ½Ï £¬*P0.05£©£¬ ±í Ã÷ »¼ Õß ÔÚ ÈÈ Á¿ Éã Èë ¼õ ÉÙºóÓªÑø×´¿ö½ÏºÃ£¬ÎÞÓªÑø²»Á¼¡£

ÌÇÄò²¡»¼ÕßÒûʳ_ÌÇÄò²¡»¼ÕßÈÑÉï_ÈÑÉïÌÇÄò²¡ÒûʳʳÆ×

GDM µÄ½á¾ÖÖ÷Ҫȡ¾ö ÓÚ ÔÐ ÆÚ Ñª ÌÇ µÄ ¿Ø ÖÆ Çé¿ö £¬GDM ·¢ ÉúÌ¥¶ù¾½ÆÈÉõÖÁ¹¬ÄÚËÀÍöµÄÔ­Òò£¬¿ÉÄÜÊÇÔи¾¸ßѪÌDZ¾Éí½µ µÍÌ¥Å̶ÔÌ¥¶ùµÄѪÑõ¹©Ó¦£¬ Ì¥¶ù¸ßѪÌǼ°¸ßÒȵºËØѪ֢¡¢Ì¥ ¶ùµÄºÄÑõÁ¿Ôö¼ÓÒײ¢·¢ÔиßÖ¢£¬ ÓֿɼÓÖØÌ¥¶ù¹¬ÄÚȱÑõ£»Ì¥ ¶ù²¡ËÀµÄÖ÷Òª»úÖÆÊÇÆÏÌÑÌÇÈÝÒ×ͨ¹ýÌ¥ÅÌ£¬Ä¸Ìå¸ßѪÌÇʱ̥ ¶ùѪÌÇÒà¸ß£¬µ«ÒȵºËز»ÄÜͨ¹ýÌ¥ÅÌ£¬Ì¥¶ùÒȵºÀɸñº±µºÔö Éú£¬µ¼ÖÂÌ¥¶ù¸ßÒȵºËØѪ֢£¬¹ýÁ¿µÄÈÈÁ¿×ª»¯ÎªÖ¬·¾£¬¹Êʹ̥ ¹ý ´ó[11]¡£ ±¾ ÑÐ ¾¿ ÖÐ GDM ÎÞ ¾Þ ´ó Ì¥ ¶ù £¬ÎÞ Ð Éú ¶ù µÍ Ѫ ÌÇ µÄ ·¢ Éú£¬ÎÞÐÂÉú¶ùÖÏÏ¢¡¢Î§Éú¶ùËÀÍö·¢Éú£¬ËµÃ÷¹æ·¶¡¢ÑϸñµÄÒûʳ ¿ØÖÆÓÐÀûÓÚ GDM Ôвú¸¾Á¼ºÃµÄÈÑÉï½á¾Ö[6]£¬¿ÉÃ÷ÏÔ¼õÉÙÐÂÉú ¶ùµÍѪÌǵķ¢ÉúÂÊ£¬ÓÐ Àû ÓÚ ÐÂÉú ¶ù Ѫ ÌÇ µÄ »Ö ¸´[12]¡£ ÓÐ ±¨ µÀ Ö¸ ³öÈÑÉïÌÇÄò²¡ºÏÀíÒûʳ¿ØÖÆ¿ÉÌṩά³ÖÈÑÉïµÄÈÈÁ¿ºÍÓªÑø£¬ ²» »á Òý Æð ¼¢ ¶ö ÐÔ µÄ ͪ Ìå ²ú Éú £¬²» Ó° Ïì Ì¥ ¶ù ·¢ Óý[13]£»ÈÑ Éï ½á ¾Ö ÓëѪÌÇˮƽ³ÊÕýÏà¹Ø ¡£ [14-15] ±¾Ñо¿½á ¹û ±í Ã÷ £¬¶ÔGDM ʵ Ê© ÑÏ ¸ñ¡¢¹æ·¶µÄ¸öÌ廯ӪÑøÖÎÁÆ£¬¸ÄÉÆѪ֬ˮƽ£¬¸ÄÉÆÓªÑø´úл£¬ ¶Ô GDM »¼ÕßÓÐÃ÷ÏÔµÄÖÎÁÆ×÷Óã¬ÄÜÓÐЧ¿ØÖÆѪÌǼ°ÌåÖØ£¬Ê¹ ÔÐ ÆÚ Ìå ÖØ Ôö ³¤ ¿Ø ÖÆ ÔÚ 10.0¡«12.5 kg[16]£¬½µ µÍ Χ Éú ÆÚ Ä¸ Ó¤ µÄ ²¢ ·¢Ö¢£¬Ê¹Ôвú¸¾»ñµÃÁ¼ºÃµÄÈÑÉï½á¾Ö£¬µ«²»ÐèÓÃÒȵºËØÖÎÁÆ£¬ ÆäÔ¶ÆÚЧ¹û»¹ÓдýÓÚ½øÒ»²½Ñо¿¡£

ÈÑÉïÌÇÄò²¡ÒûʳʳÆ×_ÌÇÄò²¡»¼ÕßÈÑÉï_ÌÇÄò²¡»¼ÕßÒûʳ

[²Î¿¼ÎÄÏ×][1] Ö쾰ϼ.ÈÑÉïÆÚÌÇÄò²¡ 384 Àý ÁÙ ´² ·Ö Îö[J].ÖÐ ¹ú Îó Õï ѧ ÔÓ Ö¾,2006,6(1): 55.14 ÖйúÒ½Ò©µ¼±¨ CHINA MEDICAL HERALD2010 Äê 5 ÔÂµÚ 7 ¾íµÚ 15 ÆÚ¡¤ÂÛ Öø¡¤Ôç·¢¹ÚÐIJ¡¼±ÐÔÐļ¡¹£ËÀ»¼ÕßµÄÁÙ´²·ÖÎöÕÅÏòȺ £¨×Ͳ©ÊÐÁÙ×ÍÇøÈËÃñÒ½ÔºÐÄÄÚ¿Æ£¬É½¶«×Ͳ© 255400£©[ÕªÒª] Ä¿µÄ£º·ÖÎöÔç·¢¹ÚÐIJ¡ £¨PCAD£©¼±ÐÔÐļ¡¹£ËÀ £¨AMI£©»¼ÕߵĴ«Í³Î£ÏÕÒòËؼ°¹Ú×´¶¯ÂöµÄ²¡±äÌص㠡£ ·½·¨£º¶Ô98Àý PCAD-AMI »¼Õߣ¨PCAD ×飩¡¢114 ÀýÍí·¢¹ÚÐIJ¡£¨LCAD£©AMI »¼Õߣ¨LCAD ×飩¼° 82 Àý·Ç¹ÚÐIJ¡Õߣ¨·Ç¹Ú×飩µÄ´«Í³Î£ÏÕÒòËؼ°¹Ú×´¶¯ÂöµÄ²¡±äÌصã½øÐзÖÎö¡£½á¹û£ºÎ£ÏÕÒòËØ·ÖÎöÏÔʾ£¬PCAD ×éÑôÐÔ¼Ò×åÊ·µÄ±ÈÂÊÏÔÖø¸ßÓÚ LCAD×飨P£¼0.01£©£»PCAD¡¢LCAD Á½×éÓë·Ç¹Ú×é±È½Ï£¬¸÷ÏîΣÏÕÒòËؾùÆ«¸ß£¬²îÒìÓÐͳ¼ÆѧÒâÒ壨P£¼0.01 »ò P£¼0.05£©¡£ ¹Ú×´¶¯ÂöÔìÓ°½á¹ûÏÔʾ£¬PCAD ×éµ¥Ö§²¡±ä±ÈÂÊ±È LCAD ×é¸ß£¨P£¼0.01£©¡£ PCAD ×éµÄµ¥Ö§±ÕÈûÂÊÓë LCAD ×éÏà½ü£¬Î´¼ûË«Ö§±ÕÈûÕß¡£ PCAD ×éµÄÿÀýµ¥¸öÖ§¼ÜÖÃÈë±ÈÂÊÏÔÖø¸ßÓÚ LCAD ×飨P£¼0.01£©¡£

ÌÇÄò²¡»¼ÕßÒûʳ_ÌÇÄò²¡»¼ÕßÈÑÉï_ÈÑÉïÌÇÄò²¡ÒûʳʳÆ×

½áÂÛ£ºPCAD-AMI »¼Õߵķ¢²¡Ó봫ͳΣÏÕÒòËØÃÜÇÐÏà¹Ø £»PCAD ×éµÄ¹Ú×´¶¯Âö²¡±äÇáÓÚ LCAD ×飻¾­ Ƥ ¹Ú Âö ½é Èë Êõ ÊÇ PCAD-AMI »¼ Õß Ê® ·Ö ÓРЧµÄ ÖÎ ÁÆ ·½ ·¨Ö®Ò»¡£[¹Ø¼ü´Ê] Ôç·¢¹ÚÐIJ¡£»¼±ÐÔÐļ¡¹£ËÀ£»¹Ú×´¶¯Âö²¡±ä£»Î£ÏÕÒòËØ[ÖÐͼ·ÖÀàºÅ] R541.4[ÎÄÏ×±êʶÂë] A[ÎÄÕ±àºÅ] 1673-7210£¨2010£©05£¨c£©-015-03Clinical analysis of premature coronary artery disease in patients with acute myocardial infarctionZHANG Xiangqun (Department of Cardiology, Linzi People's Hospital of Zibo City, Zibo 255400, China) [Abstract] Objective: To analyze the traditional risk factors and coronary lesion characteristics of patients with premature coronary artery disease (PCAD) with acute myocardial infarction (AMI). Methods: The traditional risk factors and coronary lesion characteristics of angiography and interventional treatment of 98 PCAD-AMI patients (PCAD group), 114 late-onset coronary artery disease (LCAD) AMI patients (LCAD group) and 82 non-coronary artery disease patients (non-CAD group) were analyzed. Results: Risk factor analysis showed that the ratio of positive family history of PCAD group was significantly higher than that of LCAD group (P£¼0.01); the risk factors of PCAD group and LCAD group were higher than those of nonCAD group (P£¼0.01 or P£¼0.05). Coronary angiography result showed that the incidence of single-vessel disease in PCAD group was higher than that in LCAD group (P£¼0.01). The single vessel occlusion rate of PCAD group was similar to that of LCAD group and there was no double-vessel occlusion. The single stent per patient ratio of PCAD group was significantly higher than that of LCAD group (P£¼0.01). Conclusion: PCAD-AMI is closely related to the traditional risk factors. The coronary lesions of PCAD group are lighter than those of LCAD group. Percutaneous coronary intervention is a very effective treatment for patients with PCAD-AMI. [Key words] Premature coronary artery disease; Acute myocardial infarction; Coronary lesion; Risk factorÔç ·¢ ¹Ú ÐÄ ²¡ £¨PCAD£©µÄ ¶¨ Òå Ϊ £º ¹Ú ÐÄ ²¡ µÄ ·¢ ²¡ Äê Áä ÄÐ ÐÔ £¼ 55 Ë꣬ŮÐÔ£¼65 Ëê¡£

¹ÚÐIJ¡´«Í³µÄΣÏÕÒòËØÖ÷Òª°üÀ¨Ôç·¢¹ÚÐIJ¡¼Ò×åÊ·¡¢¸ß֬Ѫ֢¡¢ÎüÑÌ¡¢¸ßѪѹºÍÌÇÄò²¡µÈ¡£ ±¾Ñо¿²É Óò¡Àý¶ÔÕÕÑо¿µÄ·½·¨£¬¶Ô PCAD ¼±ÐÔÐļ¡¹£ËÀ£¨AMI£©»¼ÕߺÍ[2] Ñî»Ûϼ,ÕÔâø,¶ÎÏþ»ª,µÈ.ÈÑÉïÆÚÌÇ´úлÒì³£¶Ôĸ¶ù½á¾ÖÓ°ÏìµÄÇ°Õ°ÐÔ ¶Ô ÕÕ ÑÐ ¾¿ [J]. ÖÐ ¹ú È« ¿Æ Ò½ Éú ,2004,7(14):1044.[3] ÖìÓñÕä,º«æÃ,Ì·¼Ñçã.ÓªÑø¸ÉÔ¤¶ÔÈÑÉïÌÇÄò²¡µÄÒâÒå[J].ͬ¼Ã´óѧѧ±¨: Ò½ ѧ °æ ,2008,29(1):87.[4] ²ÜÔóÒã.Öлª¸¾²ú¿Æѧ[M].±±¾©:ÈËÃñ³ö°æÉç,2000:15. [5] Îâ ϼ,µÔ ¹ð ÈÙ,»Æ ÐÑ.ÈÑ Éï ÆÚ ÌÇ É¸ ²é ʱ »ú µÄ ̽ ÌÖ[J].ÖÐ »ª Χ Éú Ò½ ѧ ÔÓ Ö¾,2005,8:294. [6] ÕÔÇìΰ,¹ú´ºÁá,¸ßÑÒ.¸öÌ廯µÄÒûʳ¸ÉÔ¤ÓëÔ˶¯Ö¸µ¼¶ÔÈÑÉï ÌÇ Äò ²¡ µÄÓ° Ïì[J].ÖÐ ¹ú Ò½ Ò© µ¼ ±¨,2009,6(19):61. [7] Kopp W. Role of high-insulinogenic nutrition in the etiology of gesta-tional diabetes mellitus [J]. Mes Hypotheses,2005,64(1):101-103. [8] Áõ»ÝÁÕ,ͯÄÏ Î°.ÈÑ Éï ÌÇ Äò ²¡¡ª ¡ª¡ª½â ¶Á 2004 Äê ADA ÁÙ ´² ʵ ¼ù ½¨ Òé[J].¹ú Íâ Ò½ ѧ ,2004,24(4):11-12. [9] ÓÚ ¿µ.ÁÙ ´² Óª Ñø Ò½ ʦ ËÙ ²é ÊÖ ²á [M]. ±± ¾© : ¿Æ ѧ ¼¼ Êõ ÎÄ Ï× ³ö °æ Éç ,2001:259-261. [10] Yamaoka K, Tango T. Efficacy of lifestyle education to prevent type 2diabetes: a meta-analysis of randomized controlled trials [J]. Diab Care, 2005,28(11):2780-2786. [11] ÀîÀò,Áõ´æÓ¢.Òûʳ¿ØÖƶÔÈÑÉïÌÇÄò²¡µÄÖÎÁÆ×÷ÓÃ[J].ÖйúʵÓø¾²ú¿Æ ÔÓ Ö¾ ,2000,16(11):659-660. [12] Van Howe RS, Storms MR. Hypoglycemia in infants of diabetic mothers: experience in a rural hospital [J]. Am J Perinatol,2006,23(2):105110. [13] ÕÅìÇ,ÂÞһƽ.Òûʳ¿ØÖƺÍÌÇÄò²¡É¸²éÔÚÈÑÉïÌÇÄò²¡·ÀÖÎÖеÄ×÷ÓÃ[J]. ¹ã ¶« Ò½ ѧ ,2004,25(4):433-435. [14] µË Áè,л ´ä »ª,ÂÞ Ïé ÈØ.ÈÑ Éï ÌÇ Äò ²¡ »¼ Õß Ó¦ Óà ÒÈ µº ËØ ±Ã Ç¿ »¯ ÖÎ ÁÆ ´æ ÔÚ µÄ ÎÊ Ìâ ¼° »¤ Àí ¶Ô ²ß[J].ÄÏ ·½ »¤ Àí ѧ ±¨,2005,12(10):58-59. [15] ÖÜÀöϼ,ÍõÇÉÁá.ÔÐÆÚÌåÖØÖ¸Êý¼°ÆäÔö³¤Ë®Æ½ÔÚÈÑÉïÌÇÄò²¡É¸²éÖÐµÄ Ó¦ ÓÃ[J].ÖÐ ¹ú Ò½ Ò© µ¼ ±¨,2009,6(6):26. [16] ½¯ ¼ø ·Ò.ÔÐ ¸¾ Ìå ÖØ Óë ÈÑ Éï ÌÇ Äò ²¡ ¼° ¾Þ ´ó ¶ù[J].ÖÐ ¹ú ÓÅ Éú ÓÅ Óý,2001,12 (4):150-153.£¨ÊÕ ¸å ÈÕ ÆÚ £º2010-03-17 £©CHINA MEDICAL HERALD ÖйúÒ½Ò©µ¼±¨ 15

¡¢